Patents Assigned to Bayer
  • Patent number: 6878675
    Abstract: The invention relates to a composition comprising (a) 2-(2?-nitro-4?-methylsulfonylbenzoyl)-1,3-cyclohexanedione, or an agriculturally acceptable salt or metal complex thereof; and (b) N-isopropyl-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-4-(4?-fluoro-oxycetanilide); and their use as herbicides.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: April 12, 2005
    Assignee: Bayer CropScience S.A.
    Inventors: Ken Pallett, Ashley Slater
  • Patent number: 6878708
    Abstract: Novel imidazotriazinones of general formula (I), a method for the production and the pharmaceutical use thereof are disclosed.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: April 12, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Maria Niewöhner, Mazen Es-Sayed, Thomas Lampe, Helmut Haning, Gunter Schmidt, Karl-Heinz Schlemmer, Erwin Bischoff, Klaus Dembowsky, Elisabeth Perzborn, Ulrich Niewöhner
  • Patent number: 6878358
    Abstract: Process for removing mercury from flue gases of high-temperature plants, in particular power stations and waste incineration plants in which a bromine compound is fed to the multistage furnace and/or the flue gas in a plant section downstream of the furnace, the temperature during contact of the bromine compound with the flue gas being at least 500° C., preferably at least 800° C. The combustion is carried out in the presence of a sulphur compound, in particular sulphur dioxide. Subsequently to the furnace, the flue gas is subjected to an optional multistage cleanup for removing mercury from the flue gas, which cleanup comprises a wet scrubber and/or a dry cleanup.
    Type: Grant
    Filed: May 6, 2003
    Date of Patent: April 12, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Bernhard Vosteen, Joachim Beyer, Theodore-Gerhard Bonkhofer, Olaf Fleth, Andrea Wieland, Andreas Pohontsch, Rico Kanefke, Ewa Standau, Claus Mueller, Michael Nolte, Heinz Koeser
  • Publication number: 20050075275
    Abstract: The invention relates to the use of APJ receptor agonists for producing a medicament for the treatment and/or prophylaxis of coronary heart diseases, in particular stable and unstable angina pectoris, acute myocardial infarction, myocardial infarction prophylaxis, sudden heart death, heart failure, and high blood pressure and the sequelae of atherosclerosis.
    Type: Application
    Filed: July 24, 2002
    Publication date: April 7, 2005
    Applicant: Bayer Aktiengesellschaft
    Inventors: Barbara Albrecht, Horst-Peter Antonicek, Peter Ellinghaus, Erwin Bischoff
  • Publication number: 20050075274
    Abstract: A method for determining the interaction of one or more chemical active compounds with organisms. The method comprises selecting at least one compound and analyzing its physiko-chemical and/or biochemical characteristics including its pharmacokinetic properties in various anatomical and physiological compartments of the organism in question. The relevant physiological compartments are characterized with respect to the compound's various pharmacokinetic properties that may vary with the mode of administering the compound. A combined system of coupled differential equations is then used to simulate a concentration-time curve of the active compound in selected compartments.
    Type: Application
    Filed: September 8, 2004
    Publication date: April 7, 2005
    Applicant: Bayer Technology Services GmbH
    Inventors: Stefan Willmann, Walter Schmitt, Franco Fois
  • Publication number: 20050075281
    Abstract: The invention relates to nonadepsipeptides and process for their preparation, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.
    Type: Application
    Filed: May 6, 2004
    Publication date: April 7, 2005
    Applicant: Bayer HealthCare AG
    Inventors: Franz Von Nussbaum, Nina Brunner, Sonja Anlauf, Rainer Endermann, Chantal Furstner, Elke Hartmann, Johannes Kobberling, Jacques Ragot, Guido Schiffer, Joachim Schuhmacher, Niels Svenstrup, Joachim Telser, Michael-Alexander Bruning
  • Publication number: 20050072675
    Abstract: Method and appliance for carrying out membrane electrophoresis using microfiltration or ultrafiltration membranes, wherein the electroosmotic flow which develops in the membrane pores is reduced or offset by pressure superposition.
    Type: Application
    Filed: November 13, 2003
    Publication date: April 7, 2005
    Applicant: Bayer Aktiengesellschaft
    Inventors: Gregor Dudziak, Andreas Nickel, Martina Mutter, Kerstin Baumarth
  • Publication number: 20050075338
    Abstract: This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.
    Type: Application
    Filed: September 22, 2004
    Publication date: April 7, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Derek Lowe, Philip Wickens, Xin Ma, Mingbao Zhang, William Bullock, Philip Coish, Ingo Mugge, Andreas Stolle, Ming Wang, Yamin Wang, Chengzhi Zhang, Hai-Jun Zhang, Lei Zhu, Manami Tsutsumi, James Livingston
  • Publication number: 20050074803
    Abstract: Method for determining the dose of at least one active agent based on a genetic analysis. The method comprises analyzing specific genes for their nucleotide sequence or their expression levels of gene-specific proteins and/or RNA molecules. The gene-specific data is assigned one or more relevant physiological functions of the human or animal body, in particular those which have an influence on the metabolism, absorption, excretion or distribution of the active agent in the body. The gene-specific data and the assigned physiological functions are then integrated into a physiology-based pharmacokinetic model (PBPK model). The PBPK model integrates pharmacokinetic data relating to one or more active agents. The PBPK model may also receive and evaluate patient-specific data directly inputted and combined with data from a knowledge database comprising known values of pharmacokinetic parameters. The PBPK's integration of these data provide a calculation of the individual dose of the active agent.
    Type: Application
    Filed: September 23, 2004
    Publication date: April 7, 2005
    Applicant: Bayer Technology Services GmbH
    Inventors: Walter Schmitt, Stefan Willmann, Edgar Diessel, Ingmar Dorn, Jens Burmeister
  • Patent number: 6875766
    Abstract: The invention relates to the use of riboflavin and of flavin derivatives with chitinase-inhibitory action for controlling arthropods, nematodes and chitin-containing fungi.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: April 5, 2005
    Assignee: Bayer AG
    Inventors: Andreas Turberg, Volker Gutsmann, Satosho Omura, Kazuro Shiomi
  • Patent number: 6875833
    Abstract: Disclosed are monomers which contain groups that are at least trinuclear, which are capable of absorbing the electromagnetic radiation of visible light, and which are structured such that in their thermodynamically stable state they are distended and strongly anisometric. Homopolymers prepared from such monomers, a process of preparing such homopolymers, and articles comprising such homopolymers are also disclosed. The trinuclear groups of the monomers include at least one electron-attracting substituent which gives rise to a dipole moment which forms an angle of at least 20° with the longitudinal axis of the trinuclear groups.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: April 5, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst Berneth, Uwe Claussen, Serguei Kostromine, Ralf Neigl, Hans-Joachim Vedder
  • Patent number: 6875783
    Abstract: Novel isothiazolecarboxamides of the formula in which R is as defined in the description, a plurality of processes for preparing the novel compounds and their us for protecting plants against attack by undesirable microorganisms and animal pests.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: April 5, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Lutz Assmann, Dietmar Kuhnt, Hans-Ludwig Elbe, Christoph Erdelen, Stefan Dutzmann, Gerd Hänssler, Klaus Stenzel, Astrid Mauler-Machnik, Yoshinori Kitagawa, Haruko Sawada, Haruhiko Sakuma
  • Publication number: 20050070541
    Abstract: The 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position are prepared from the corresponding 2-phenyl-imidazotriazinones by chlorosulphonation and subsequent reaction with the amines. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of cardiovascular and cerebrovascular disorders and/or disorders of the urogenital system, in particular for the treatment of erectile dysfunction.
    Type: Application
    Filed: August 20, 2004
    Publication date: March 31, 2005
    Applicant: Bayer Aktiengesellschaft
    Inventors: Ulrich Niewohner, Mazen Es-Sayed, Helmut Haning, Thomas Schenke, Karl-Heinz Schlemmer, Jorg Keldenich, Erwin Bischoff, Elisabeth Perzborn, Klaus Dembowsky, Peter Serno, Marc Nowakowski
  • Publication number: 20050070437
    Abstract: Herbicide combinations having an effective content of components (A), (B) and (C) have improved properties as crop protection compositions: (A) is one or more herbicides selected from the group consisting of the compounds of the formula (I) and their salts, (B) is one or more herbicides selected from the group consisting of the compounds of the formula (II) and their salts, (C) is one or more herbicides which act selectively in some monocotyledonous crops against monocotyledonous and/or dicotyledonous harmful plants, which herbicides are selected from the group consisting of the compounds (C1) diflufenican, (C2) imazamox, (C3) florasulam, (C4) halosulfuron, (C5) tritosulfuron, (C6) picolinafen, (C7) cinidon-ethyl, (C8) mesotrione, (C9) metosulam, (C10) copyralid, (C11) flufenacet, (C12) flumetsulam, (C13) flupoxam, (C14) prosulfocarb, (C15) flurtamone, (C16) aclonifen, (C17) fenoxaprop, (C18) isoproturon, (C19) diclofop, (C20) clodinafop, (C21) chlortoluron, (C22) methabenzthiazuron, (C23) imazamethab
    Type: Application
    Filed: July 28, 2004
    Publication date: March 31, 2005
    Applicant: Bayer CropScience GmbH
    Inventors: Erwin Hacker, Martin Hess, Frederic Top, Wolfgang Benz, Markus Dollinger
  • Publication number: 20050071899
    Abstract: The present invention relates to new DNA sequences, a method for producing new plants which contain a new DNA sequence, the coding sequence thereof being expressed after ozone induction. The invention also relates to said new plants and the use of DNA sequences to produce ozone-responsive gene expression in plants and plant cells. Moreover, it relates to a new promoter, the specificity thereof being increased by removal of the ozone response capacity thereof.
    Type: Application
    Filed: January 8, 2004
    Publication date: March 31, 2005
    Applicants: GSF - FORSCHUNGSZENTRUM FUR UMWELT, BAYER AG
    Inventors: Roland Schubert, Heinrich Sandermann, Dietrich Ernst, Rudiger Hain, Regina Fischer
  • Publication number: 20050070582
    Abstract: The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.
    Type: Application
    Filed: September 4, 2002
    Publication date: March 31, 2005
    Applicant: Bayer Healthcare AG
    Inventors: Yingfu Li, Akihiko Watanabe, Timothy Lowinger, Kevin Bacon, Norihiro Kawamura, Takuya Shintani, Tetsuo Kikuchi, Toshiya Moriwaki, Klaus Urbahns, Keiko Fukushima, Noriko Nunami, Takashi Yoshino, Toshiki Murata, Megumi Yamauchi, Hiroko Yoshino
  • Patent number: 6872780
    Abstract: A butyl polymer composition having improved cold flow properties is described. The composition comprises a butyl polymer (preferably a halogenated butyl polymer) and a styrene monomer. The styrene monomer is a copolymer of ?-methylstyrene and another styrenic monomerer (e.g., styrene and vinyl toluene). Relative to the base butyl polymer, the cold flow properties of the butyl polymer composition are improved along with a number of other properties.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: March 29, 2005
    Assignees: Bayer Inc., Bayer Aktiengesellschaft
    Inventors: Richard Pazur, Anthony J. Sumner
  • Patent number: 6872691
    Abstract: What is described are herbicidal compositions comprising herbicidal compounds of the formula I and a compound which acts as safener. In the formula I, the symbols R1 to R4 denote hydrogen, halogen, alkyl and haloalkyl.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: March 29, 2005
    Assignee: Bayer CropScience GmbH
    Inventors: Monika H. Schmitt, Lothar Willms, Frank Ziemer, Christopher Rosinger, Hermann Bieringer, Philipp Huff, Erwin Hacker
  • Patent number: 6872861
    Abstract: The invention relates to a process for preparing polyfluoroalkyl-lithium compounds by deprotonation of polyfluoroalkyl compounds by means of lithium bases.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: March 29, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Marielouise Schneider, Albrecht Marhold, Alexander Kolomeitsev, Alexander Kadyrov, Gerd-Volker Röschenthaler, Jan Barten
  • Patent number: 6872847
    Abstract: This invention relates to a process for the preparation of alkyl-N-(3-dimethylamino)alkylcarbamates by reacting an alkyl-chloroformate in an alcohol.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: March 29, 2005
    Assignee: Bayer Cropscience GmbH
    Inventors: Johannes Keuchel, Günter Schlegel